André Calantzopoulos on Profiting from Nicotine

PSYCHOACTIVE

Indhold leveret af iHeartPodcasts and Protozoa. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af iHeartPodcasts and Protozoa eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

2+ y ago 56:07

MP3•Episode hjem

Philip Morris International (PMI) is a leader in Big Tobacco, profiting from the sale of Marlboro, Chesterfield, Virginia Slims and other cigarette brands. It’s also at the forefront in transitioning to the sale of non-combustible nicotine products, which now make up 30% of PMI’s revenue. André Calantzopoulos has worked for PMI for almost forty years, most recently as CEO and now executive chairman. We talked about the opportunities and challenges PMI confronts in making this transition. I pressed him on why PMI still opposes some government regulations to limit smoking. Is their ultimate objective to replace the market for cigarettes with an even bigger market for less dangerous forms of nicotine consumption? What about the potential medical value of nicotine? Do they have plans to get more deeply involved in the cannabis industry? And why did he decide, as a young man, to go to work for Big Tobacco?
Listen to this episode and let me know what you think. Our number is 1-833-779-2460. Our email is psychoactive@protozoa.com. Or tweet at me, @ethannadelmann.

See omnystudio.com/listener for privacy information.

Kapitler

1. André Calantzopoulos on Profiting from Nicotine (00:00:00)

2. Ad Break 1 (00:20:22)

3. Ad Break 2 (00:42:08)

89 episoder

#Fitness #Society #iHeartRadio and Protozoa